Efficacy of MIrikizumab to Achieve Transmural Healing in patiENTs With Crohn's Disease

Abroad (travel likely)RecruitingPHASE4

Conditions

Crohn Disease (CD)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

CHU de Brest - Hôpital de la Cavale Blanche, Brest, France
Contact: Study coordinator (Franck CHOLET, MD) · franck.cholet@chu-brest.fr · +33 2 98 34 71 15
CHU de Clermont Ferrand - Hôpital d'Estaing, Clermont-Ferrand, France
Contact: Study coordinator (Anthony BUISSON, MD) · a_buisson@chu-clermontferrand.fr · +33 4 73 75 05 23
CHU de Nîmes Carémeau, Nîmes, France
Contact: Study coordinator (Ludovic CAILLO, MD) · Ludovic.CAILLO@chu-nimes.fr · +33 4 66 68 31 83
Institut Mutualiste Monsouris, Paris, France
Contact: Study coordinator (Marion SIMON, MD) · Marion.Simon@imm.fr · +33 1 56 61 63 14
CHU de Toulouse - Hôpital Rangueil, Toulouse, France
Contact: Study coordinator (Cyrielle GILLETTA, MD) · gilletta.c@chu-toulouse.fr · +33 5 61 32 27 63
CH de Valence, Valence, France
Contact: Study coordinator (Céline MONTUCLARD, MD) · cmontuclard@ch-valence.fr · +33475757512

Study leads

Anthony BUISSON, MD
Principal Investigator
University Hospital, Clermont-Ferrand
Guillaume LE COSQUER, MD
Principal Investigator
CHU de Toulouse- Hôpital Rangueil

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

TNFi Plus Low-Dose Upadacitinib vs TNFi Intensification in Crohn's Disease With Suboptimal Response

Crohn Disease (CD)

Abroad (travel likely)RecruitingPHASE4

Guangzhou, China

De-escalation of Ustekinumab Therapy in Patients With Crohn's Disease and Ulcerative Colitis

Crohn Disease (CD) · Ulcerative Colitis (UC)

Abroad (travel likely)RecruitingPHASE4

Montreal, Canada

Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)

Inflammatory Bowel Disease (IBD) · Crohn Disease (CD) · Ulcerative Colitis (UC)

Abroad (travel likely)Recruiting

Calgary, Canada · Fredericton, Canada

Comparison of the Efficacy of Different Biologic Agents in Preventing Postoperative Endoscopic Recurrence of Crohn's Disease

Inflamatory Bowel Disease · Crohn Disease (CD)

Abroad (travel likely)Recruiting

Shanghai, China